Catalog No.
PHC83601
Species reactivity
Human, Mouse, Rat
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant Human ESD (Met1-Ala282).
Tested applications
ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000
Target
S-formylglutathione hydrolase, Esterase D, FGH, Methylumbelliferyl-acetate deacetylase, ESD
Purification
Purified by antigen affinity column.
Accession
P10768
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Expert Opinion on the Management, Challenges, and Knowledge Gaps Pertaining to Eosinophilic Esophagitis Among Adults in the Greater Gulf Region., PMID:40385617
Implementation of a seamless phase 2/3 study design in the setting of an emergent infectious disease pandemic: Lessons learned from the ACTIV-2 platform COVID-19 treatment trial., PMID:40147543
Tixagevimab/cilgavimab or placebo for COVID-19 in ACTIV-2: Safety, pharmacokinetics and neutralizing and anti-drug antibodies., PMID:40124489
Revealing autoimmune gastritis: Polypoid nodule scar development after endoscopic submucosal dissection for early gastric cancer., PMID:40070929
[A Case in Which Pembrolizumab Was Effective for Synchronous Urothelial Carcinoma, Gastric Cancer and Cecal Cancer]., PMID:39948934
Symptomatic Improvement in Adults and Adolescents With Eosinophilic Esophagitis Requires Higher Systemic Dupilumab Exposure Than Histologic Response., PMID:39853721
Safety and Immunogenicity Study of a Bivalent Vaccine for Combined Prophylaxis of COVID-19 and Influenza in Non-Human Primates., PMID:39460266
Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled Trial., PMID:39400063
Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial., PMID:39028902
SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19., PMID:39018444
Dupilumab Improves Health-Related Quality of Life and a Range of Symptoms in Patients With Eosinophilic Esophagitis., PMID:38940435
Single-Molecule Identification of the Isomers of a Lipidic Antibody Activator., PMID:38935930
Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis., PMID:38924732
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age., PMID:38924731
Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial., PMID:38746756
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody., PMID:38635853
Expression of the SARS-CoV-2 receptor-binding domain by live attenuated influenza vaccine virus as a strategy for designing a bivalent vaccine against COVID-19 and influenza., PMID:38589848
Advanced Diagnostic and Therapeutic Endoscopy for Early Gastric Cancer., PMID:38473395
HIV-1 envelope diversity and sensitivity to broadly neutralizing antibodies across stages of acute HIV-1 infection., PMID:38416554
Mucosal esophageal carcinoma following endoscopic submucosal dissection with giant gastric metastasis: A case report and review of literature., PMID:38111508
Histopathological features of glandular atrophy of the lamina propria of the gastric mucosa during its occurrence and development., PMID:37968594
Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial., PMID:37855026
A Case in Which Breast Cancer Developed at the Same Time As Dermatomyositis, and the Onset of New Cancer Was Able to Be Predicted by the Exacerbating Skin Symptoms and Parallel Increase in the Anti-TIF1-γ Antibody Levels., PMID:37839875
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody., PMID:37745410
Long COVID After Bamlanivimab Treatment., PMID:37650236
ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients., PMID:37650231
Association Between Anterior Nasal and Plasma SARS-CoV-2 RNA Levels and Hospitalization or Death in Nonhospitalized Adults With Mild-to-Moderate COVID-19., PMID:37650230
Application of polyglycolic acid sheets and basic fibroblast growth factor to prevent esophageal stricture after endoscopic submucosal dissection in pigs., PMID:37635203
Mepolizumab for treatment of adolescents and adults with eosinophilic oesophagitis: a multicentre, randomised, double-blind, placebo-controlled clinical trial., PMID:37423717
Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19., PMID:37068272
Repeated bleeding caused by acquired hemophilia A after endoscopic submucosal dissection: A case report and literature review., PMID:36845961
Development of an automated chemiluminescent immunoassay for cancer antigen 72-4 and the evaluation of its analytical performance., PMID:36713933
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19., PMID:36661240
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis., PMID:36546624
Long-term outcome of metachronous, multiple, early Epstein-Barr virus-associated gastric carcinoma: a case report., PMID:36388697
HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial., PMID:36374768
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial., PMID:36289399
Sessile droplet array for sensitive profiling of multiple extracellular vesicle immuno-subtypes., PMID:36201999
Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19., PMID:35995785
Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection., PMID:35793677
Curative resection with endoscopic submucosal dissection of early gastric cancer in Helicobacter pylori-negative Ménétrier's disease: A case report., PMID:35316958
The Impact of Inflammation on the Immune Responses to Transplantation: Tolerance or Rejection?, PMID:34880853
Flow Cytometry Immunophenotyping for Diagnostic Orientation and Classification of Pediatric Cancer Based on the EuroFlow Solid Tumor Orientation Tube (STOT)., PMID:34638431
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine., PMID:34587382
[Two Serum Free Light Chain Detection Systems in the Diagnosis of Multiple Myeloma]., PMID:34362504
Electrostatic spray drying for monoclonal antibody formulation., PMID:34324986
Molecular determinants of response to PD-L1 blockade across tumor types., PMID:34172722
A case of Helicobacter pylori -negative early gastric adenocarcinoma with gastrointestinal phenotype., PMID:34079868
Vonoprazan vs lansoprazole for the treatment of artificial gastric ulcer after endoscopic submucosal dissection: a prospective randomized comparative study., PMID:34025030
Endoscopic submucosal dissection is safe and feasible, allowing for ongoing surveillance and organ preservation in patients with inflammatory bowel disease., PMID:34021968
For research use only. Not for human or drug use.
